MDL Mass Tort & Class Action Monitor
Developed to serve primarily as a litigation scouting report for plaintiff and defense counsel, insurers and legal service providers, HarrisMartin’s MDL Mass Tort & Class Action Monitor covers significant new filings and decisions in the JPML, MDL and related mass tort arenas. The quick delivery of breaking news and additional features will keep you within close range of every development occurring in the high-stakes environment of mass torts litigation — where minutes can make a difference. The MDL Mass Tort & Class Action Monitor is an online-only offering that includes frequent email updates and is available at no charge to annual and event sponsors of HarrisMartin’s CLE Conferences.
SEARCH THE ARCHIVES
Issue #34, December 2019
Victims who accuse major hotel chains of failing to implement policies to prevent sex trafficking activity on their premises have asked the Judicial Panel on Multidistrict Litigation to create a federal docket for their lawsuits.
A Pennsylvania federal judge has remanded a multi-plaintiff Essure case for lack of federal jurisdiction, finding there is no actual dispute about the interpretation of federal law.
A federal appeals court has reinstated Racketeer Influenced and Corrupt Organization Act claims accusing the maker of Actos of failing to warn prescribing doctors of a link between type 2 diabetes drug Actos and bladder cancer.
Class Action Alleging Link Between Allergan Biocell Implants and Rare Cancer Filed in Mich. Federal Court
DETROIT — Women who allege they developed symptoms of a rare immune system cancer after being implanted with Allergan’s BIOCELL line of textured breast implants have filed a class action seeking compensation for surgery to remove their implants, medical monitoring, and other medical expenses.
A federal appeals court has reinstated a Pennsylvania woman’s lawsuit alleging injuries caused by Zimmer Inc.’s Kinectiv Technology hip implant system with a VerSys femoral head, ruling that a jury must decide whether her claims are timely.
Zantac Defendants Support Efforts to Create MDL Docket; Agree with District of New Jersey as Destination
Defendants named in Zantac personal injury lawsuits have supported recent plaintiff efforts to create a multidistrict litigation docket for the growing number of cases, agreeing with the petitioner’s suggestion that the cases be centralized in the District of New Jersey.
A plaintiff with claims pending against Allergan for its Biocell textured breast implants has opposed the suggested location of the proposed multidistrict litigation docket, arguing instead that the Southern District of Florida is the “best venue choice, because its docket conditions are much more favorable than those of the other districts under consideration.”
C-8 MDL Court Awards Plaintiffs Summary Judgment on Application of Collateral Estoppel to Certain Issues
The federal court overseeing the multidistrict litigation docket for C-8 personal injury claims has awarded plaintiffs summary judgment on the application of collateral estoppel to certain issues, saying the move was justified given, in part, that DuPont settled the only remaining bellwether cases, therefore leaving no bellwether cases unresolved.
A Maryland federal judge has denied Smith & Nephew Inc.’s request to make appealable a ruling that claims relating to the “hybrid” Birmingham Hip Resurfacing-THA and R3-THA hip replacement systems and components are not preempted.
The 3rd Circuit U.S. Court of Appeals has remanded thousands of Fosamax cases to New Jersey federal court for a determination as to whether federal law preempts the plaintiffs’ claims.